TY - JOUR
T1 - Development of an off-line heart cutting two-dimensional HPLC system for enantioselective analysis of serine, threonine and allo-threonine in human physiological fluids
AU - Oyaide, Mai
AU - Furusho, Aogu
AU - Ishii, Chiharu
AU - Akita, Takeyuki
AU - Mita, Masashi
AU - Ide, Tomomi
AU - Hamase, Kenji
N1 - Funding Information:
This study was partly supported by JSPS (Japan Society for the Promotion of Science, Japan) KAKENHI Grant Numbers JP19H03359 and JP19K07027 . The authors appreciate KAGAMI, Inc. (Osaka, Japan) for their technical support.
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/8/5
Y1 - 2022/8/5
N2 - A highly-selective two-dimensional high-performance liquid chromatographic (2D-HPLC, off-line heart cutting mode) system was developed for the determination of serine (Ser), threonine (Thr) and allo-threonine (aThr) enantiomers in human physiological fluids. Ser, Thr and aThr have a hydroxy group in their side chains, and the development of a simultaneous analytical method with a practically sufficient enantio/chemo-selectivity has been required to clarify their amounts in human physiological fluids. The amino acids in the samples were derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole and were isolated by a reversed-phase column (Singularity RP18, 1.0 x 250 mm) in the first dimension. After the target amino acids were collected, the fractions were manually introduced into an enantioselective column in the second dimension and were detected by their fluorescence. For the second dimension, a Pirkle-type chiral stationary phase (Singularity CSP-013S, 1.5 x 250 mm) was used. The resolution values of the enantiomers obtained by the Singularity CSP-013S column were 7.64 for Ser, 7.58 for Thr and 4.71 for aThr by using the mixture of methanol and acetonitrile containing formic acid as the mobile phases. The developed method was validated and applied to human plasma and urine. In the plasma, the obtained %D values (the percentage of D-form to total amino acid) were 1.7 for Ser, and trace levels of D-aThr and D-Thr were observed. In the urine, the %D values were 48.0 for Ser, 1.6 for Thr and 8.0 for aThr (calculated using D-aThr and L-Thr).
AB - A highly-selective two-dimensional high-performance liquid chromatographic (2D-HPLC, off-line heart cutting mode) system was developed for the determination of serine (Ser), threonine (Thr) and allo-threonine (aThr) enantiomers in human physiological fluids. Ser, Thr and aThr have a hydroxy group in their side chains, and the development of a simultaneous analytical method with a practically sufficient enantio/chemo-selectivity has been required to clarify their amounts in human physiological fluids. The amino acids in the samples were derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole and were isolated by a reversed-phase column (Singularity RP18, 1.0 x 250 mm) in the first dimension. After the target amino acids were collected, the fractions were manually introduced into an enantioselective column in the second dimension and were detected by their fluorescence. For the second dimension, a Pirkle-type chiral stationary phase (Singularity CSP-013S, 1.5 x 250 mm) was used. The resolution values of the enantiomers obtained by the Singularity CSP-013S column were 7.64 for Ser, 7.58 for Thr and 4.71 for aThr by using the mixture of methanol and acetonitrile containing formic acid as the mobile phases. The developed method was validated and applied to human plasma and urine. In the plasma, the obtained %D values (the percentage of D-form to total amino acid) were 1.7 for Ser, and trace levels of D-aThr and D-Thr were observed. In the urine, the %D values were 48.0 for Ser, 1.6 for Thr and 8.0 for aThr (calculated using D-aThr and L-Thr).
UR - http://www.scopus.com/inward/record.url?scp=85129937040&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129937040&partnerID=8YFLogxK
U2 - 10.1016/j.jpba.2022.114807
DO - 10.1016/j.jpba.2022.114807
M3 - Article
C2 - 35567854
AN - SCOPUS:85129937040
SN - 0731-7085
VL - 217
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
M1 - 114807
ER -